Essence Vitality Wellness e-Library

 A Polish study (2014) and a Spanish study (2016) concluded that  “Craniosacral therapy reduces the resting tension of the multifidus  muscle in patients with non-specific lumbosacral pain” and “Ten sessions  of craniosacral therapy resulted in a statistically greater improvement  in pain intensity, hemoglobin oxygen saturation, systolic blood  pressure, serum potassium, and magnesium level than did 10 sessions of  classic massage in patients with low back pain.” 

 A 2009 study showed "Craniosacral Therapy was  found to be an effective means for treating lower urinary tract symptoms  (UTIs) and improving quality of life in Multiple Sclerosis (MS)  patients".  The International Association of Healthcare Practitioners  states Cranioscarl Therapy "can help improve mobility in the  neurological system, reduce neurological pain, and improve balance", and  people in a 2014 UK Overcoming MS patient forum discuss how  Craniosacral Therapy has effectively treated their symptoms. 

 MD swallows pride around CST and declares, "wow, that's awesome!"    Hence, when I saw this new craniosacral therapy research, I wasn’t that  surprised. I had seen these CSF flow studies at medical conferences and  knew that they opened up a whole new world of study in how certain  diseases, like Alzheimer’s, multiple sclerosis, and certain pain  conditions, may be linked to blockages in this flow. Why? The CSF is  both the cooling system and waste removal for the brain, spinal cord,  and nerve roots. 

 MD swallows pride around CST and declares, "wow, that's awesome!"  We arrogant MDs needed to write an apology to our alternative medicine  colleagues based on new discoveries that showed that craniosacral  therapy works. Now another new study shows just how stupid we have been,  finding new lymph connections in the brain that would further explain  why craniosacral therapy is effective as well as chart a link between  the immune system and the brain. 

POTS is a rare disorder of  the autonomic nervous system. The number of people afflicted with this  dysautonomia has increased dramatically in recent years due to the  long-term effects of coronavirus disease (COVID-19). This 2023 case report is about a patient with  post-viral neuropathic POTS.  We found that the CV4 technique led to the successful remission of the  patient’s symptoms. Therefore, we propose craniosacral therapy as a  successful single management modality in patients with POTS. 

Craniosacral Therapy and Visceral Manipulation are showing to be a new treatment intervention for concussion recovery.  TBI (Traumatic Brain Injury) cause multiple health issues.  2014-2015 study shows "Ten sessions of specific craniosacral, visceral manipulation, and neuromeningeal manipulation therapy resulted in statistically greater improvements in pain intensity, ROM, memory, cognition, and sleep in concussed patients."

 "What’s broadly understood is research indicates that there is a link between Long COVID and the brainstem.  Neuroscientists conducted a study proposing COVID-19 invasion of the brainstem may be responsible for the  persistent neurological symptoms (specifically neurodegeneration) observed in Long-COVID patients.  This phenomenon, known as COVID-19 tropism, leads to the virus gathering, replicating and further infecting the body through ‘hijacking’ the Mitochondria... “Long Haulers” should know  that relieving symptoms can be achieved through a treatment combining  chiropractic care and craniosacral therapy." 

 "Hemodynamic and cardiopulmonary parameters are above all influenced by  the heart and brain centres, besides peripheral resistance.  An increase in the parasympathicotonia and vagal hypertonia induced by  biodynamic craniosacral therapy  can directly lead to a reduction in the frequency of firing of sinoatrial and atrioventricular nodes, modifying  the hemodynamic and ventilatory parameters. Even if further in-depth  studies are necessary to confirm our hypothesis and experiences, this  therapeutic perspective could potentially provide a robust tool to  approach the cardiovascular patophysiology."   

"Clinical trials have revealed significant effects of CST (cranioscacral) in addition to treatment and effectiveness compared to standard  therapies in e.g. patients suffering from chronic pain conditions, infantile colic, attention deficit hyperactivity disorder, and asthma.

Beyond  that, patients report using CST as a complementary treatment strategy  for headaches and migraine, dizziness and tinnitus, gastrointestinal  disorders as well as stress-related and mental problems like depression  and anxiety. In children, CST is used to support symptom alleviation of respiratory,  oncological, allergic, autism spectrum, and gastroenterological  diseases. In the UK and Switzerland, NHS cancer centers and psychiatric university hospitals have established treatment concepts integrating CST into conventional in- and out-patient care.